Trial Search Results

Biomarkers for the Detection of Lymphatic Insufficiency

Acquired lymphedema is a disease that causes chronic swelling of the limb(s). It is frequently under-recognized or misdiagnosed. This study is designed to lead to the development of an accurate, noninvasive, blood test to allow testing for lymphedema. This approach is particularly useful to investigate relative responses to treatment interventions.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Procedure: phlebotomy
  • Other: Measurement of skin thickness by caliper
  • Other: Limb volume quantitation by circumferential measurements

Eligibility


Inclusion Criteria:

For lymphedema participants:

history of acquired lymphedema of at least 6 months' duration.

Control participants: no evidence of lymphedema, no lymph node dissection, no radiation
therapy, active inflammatory disease

Exclusion Criteria:

active cancer, infection or bleeding tendency active coronary artery disease, congestive
heart failure history of stroke or TIA uncontrolled hypertension Renal insufficiency (serum
creatinine > 1.1) Active inflammatory or autoimmune disease (other than lymphedema)

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Recruiting